Comorbidity acquired before HIV diagnosis and mortality in persons Infected and Uninfected with HIV: A Danish population-based cohort study

Journal of Acquired Immune Deficiency Syndromes

Volumn 57, Issue 4, 2011, Pages 334-339

  Lohse, Nicolai ^a,g   Gerstoft, Jan ^b   Kronborg, Gitte ^c   Larsen, Carsten Schade ^a   Pedersen, Court ^d   Pedersen, Gitte ^e   Nielsen, Lars ^f   Sørensen, Henrik Toft ^a   Obel, Niels ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Rigshospitalet   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e AALBORG UNIVERSITY HOSPITAL   (Denmark)

^f Nordsjællands Hospital Hillerød   (Denmark)

^g NONE   (Denmark)

Author keywords

cohort study; comorbidity; HIV; mortality; population based

Indexed keywords

ADULT; ARTICLE; ATTRIBUTABLE RISK; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DENMARK; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NONHUMAN; OUTCOME VARIABLE; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGISTER; SURVIVAL RATE;

ADULT; CAUSE OF DEATH; COHORT STUDIES; COMORBIDITY; DENMARK; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; VITAL STATISTICS;

EID: 79959947558     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31821d34ed     Document Type: Article

References (32)

1. Sterne JA, Hernan MA, Ledergerber B, et al. Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet. 2005;366:378-384. (Pubitemid 41073955)
2. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med. 2007; 146:87-95. (Pubitemid 351640011)
3. Friis-Moller N, Reiss P, Sabin CA, et al. Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med. 2007;356:1723-1735. (Pubitemid 46658704)
4. Obel N, Thomsen HF, Kronborg G, et al. Ischemic heart disease in HIVinfected and HIV-uninfected individuals: a population-based cohort study. Clin Infect Dis. 2007;44:1625-1631. (Pubitemid 46871511)
5. Wyatt CM, Rosenstiel PE, Klotman PE. HIV-associated nephropathy. Contrib Nephrol. 2008;159:151-161.
6. Pantanowitz L, Schlecht HP, Dezube BJ. The growing problem of non-AIDS-defining malignancies in HIV. Curr Opin Oncol. 2006;18:469-478. (Pubitemid 44199843)
7. Phillips A. Morbidity and mortality in the HAARTera. In: 15th Conference on Retroviruses and Opportunistic Infections; 2008. Abstract 8.
8. Lucas SB, Curtis H, Johnson MA. National review of deaths among HIVinfected adults. Clin Med. 2008;8:250-252. (Pubitemid 351960975)
9. Panos G, Samonis G, Alexiou VG, et al. Mortality and morbidity of HIV infected patients receiving HAART: a cohort study. Curr HIV Res. 2008; 6:257-260. (Pubitemid 352024678)
10. Novoa AM, de Olalla PG, Clos R, et al. Increase in the non-HIV-related deaths amongAIDScases in theHAARTera. Curr HIV Res. 2008;6:77-81. (Pubitemid 351461025)
11. Martinez E, Milinkovic A, Buira E, et al. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area. HIV Med. 2007;8:251-258. (Pubitemid 46695372)
12. Braithwaite RS, Justice AC, Chang CC, et al. Estimating the proportion of patients infected with HIV who will die of comorbid diseases. Am J Med. 2005;118:890-898. (Pubitemid 41097468)
13. Hansen AB, Gerstoft J, Kronborg G, et al. Mortality in siblings of patients coinfected with HIV and hepatitis C virus. J Infect Dis. 2007;195: 230-235. (Pubitemid 46080055)
14. Delpierre C, Cuzin L, Lauwers-Cances V, et al. Unemployment as a risk factor for AIDS and death for HIV-infected patients in the era of highly active antiretroviral therapy. Sex Transm Infect. 2008;84:183-186. (Pubitemid 351871489)
15. Tai JH, Udoji MA, Barkanic G, et al. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis. 2007;196:1044-1052. (Pubitemid 47580299)
16. Matthews GV, Dore GJ. HIV and hepatitis C coinfection. J Gastroenterol Hepatol. 2008;23:1000-1008. (Pubitemid 352019390)
17. Weis N, Lindhardt BO, Kronborg G, et al. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clin Infect Dis. 2006;42:1481-1487.
18. Obel N, Engsig FN, Rasmussen LD, et al. Cohort profile: the Danish HIV cohort study. Int J Epidemiol. 2009;38:1202-1206.
19. Lohse N, Hansen AB, Jensen-Fangel S, et al. Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study. Scand J Infect Dis. 2005;37:338-343. (Pubitemid 40691514)
20. Pedersen CB, Gøtzsche H, Møller JØ, et al. The Danish Civil Registration System. A cohort of eight million persons. Dan Med Bull. 2006;53: 441-449.
21. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. Avaluable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
22. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
23. de Groot V, Beckerman H, Lankhorst GJ, et al. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol. 2003;56:221-229. (Pubitemid 36513483)
24. Christensen PB. Epidemiology of hepatitis C [in Danish]. Ugeskr Laeger. 1998;160:3529-3532.
25. Rothman KJ. Epidemiology: An Introduction. New York, NY: Oxford University Press; 2002.
26. Assmann SF, Hosmer DW, Lemeshow S, et al. Confidence intervals for measures of interaction. Epidemiology. 1996;7:286-290. (Pubitemid 26120376)
27. Last JM. A Dictionary of Epidemiology. New York, NY: Oxford University Press; 2000.
28. Hansen AB, Lohse N, Gerstoft J, et al. Cause-specific excess mortality in siblings of patients co-infected with HIVand hepatitis C virus. PLoS One. 2007;2:e738.
29. Lohse N, Hansen AB, Gerstoft J, et al. Improved survival in HIV-infected persons: consequences and perspectives. J Antimicrob Chemother. 2007; 60:461-463. (Pubitemid 47303950)
30. Bhavan KP, Kampalath VN, Overton ET. The aging of the HIV epidemic. Curr HIV /AIDS Rep. 2008;5:150-158.
31. Goulet JL, Fultz SL, Rimland D, et al. Aging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity? Clin Infect Dis. 2007;45:1593-1601. (Pubitemid 351411845)
32. Wierzbicki AS, Purdon SD, Hardman TC, et al. HIV lipodystrophy and its metabolic consequences: implications for clinical practice. Curr Med Res Opin. 2008;24:609-624. (Pubitemid 351428972)